NCT02828124

A Study of the Safety and Tolerability of BMS-986183 in Patients With Liver Cancer

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: TERMINATED

Phase: PHASE1, PHASE2

Sponsor: Bristol-Myers Squibb

Condition: Hepatocellular Carcinoma

Signal summary

Public flags

Status signal: Registry Stop Signal

Timeline signals: stale_update_signal

Results signal: Low Signal

Operational burden: None

Stopped reason

Context when available

Business objectives have changed